The Covid-19 pandemic is a situation that will have long lasting effects in our global economy. The outbreak showcases the value of digital operating models and is likely to force many companies to speed up their digital innovation and transformation.
For this assignment, please consider the following scenarios:
You must Identify an organization that has been significantly affected by the COVID-19 outbreak and recommend how the organization can leverage digital innovation to sustain the business and enable growth.
To do so , you must propose a change in its operating model, supported by digital efforts, that will mitigate the impact during the crisis.
You must describe which business processes would be affected and describe the capabilities and elements that will enable these changes.
Criteria for selecting an organization:
– The organization must be a mid-sized company with more than just one customer-relations office or retail outlet
– The organization must have an existing (pre-Covid-19) business strategy and business model that you will describe and use as a basis for your discussion
– The existing business strategy and model you identify will then be used to evaluate the extent to which the organization has been affected by the Covid-19 crisis
– The existing busines and model you identify will then be used to evaluate the relevance of the 5 steps, below, for your analysis and proposed solutions.
– The organization you select must have its information in open online sources and it must be in English.
provide an individual Project Report which covers theoretical application of a digital business strategy, including the development and recommendations for a digital transformation solution in the organization. Demonstration of the use of digital interface, applications and understanding of new business models and disruption are expected.
compromise the following 5 steps of analysis and discussion:
1. Audit of the current landscape od the organization’s industry sector
2. Evaluation of the competitive environment
3. Definition of SMART objectives, strategies, and tactics
SWOT of the current landscape and TOWS matrix of proposed solution
Outline of the proposed solution implementation.
includes, but not limited to, solid-lipid nanoparticles, gold nanoparticles, silver nanoparticles, mesoporous silica nanoparticles, nanocrystals, magnetic nanoparticles, carbon nanotubes, nanosponges, albumin nanoparticles, fullerene nanoparticles and polymeric nanoparticles[1-4].
Nanotechnology offers many advantages to drug delivery systems and the molecular imaging field as well as having the potential to literally revolutionize both of these fields. In terms of drug delivery systems, liposomes, micelles, dendrimers, and metal colloidals (diameters less than 100 nm) have been extensively studied to enhance the efficacy of therapeutic agents [5-9].
Owing to their small size and excellent biocompatibility, nanosized drug carriers can travel in the bloodstream for a long time, enabling them to reach a target site and effectively deliver therapeutic agents, all the while minimizing the inefficiency and side effects of free drugs.
In spite of the extensive research and success stories with other routes for drug delivery, the oral route is still the most favored route as a result of its convenience, low cost, and high patient compliance compared with numerous further routes. About 90 percent of drug products are administered via the oral route [10]. But, the oral route isn’t the most efficient route for a particular therapy. Novel drug delivery technologies are essential for new biological drugs such as nucleic acids and proteins in order to diminish the possible side effects and attain better patient compliance [11, 12].
The latest advances in nanotechnologies, especially in nanoparticles, make them very promising in the delivery of therapeutics, drug discovery and diagnostics [13].
The delivery of therapeutic compound to the target site is a major trouble in the treatment of various diseases. A conventional application of drugs is characterized by limited effectiveness, poor biodistribution, and lack of selectivity [14]. The nanoparticles (NPs) as drug delivery systems may offer a number of advantages such as protection of drugs against degradat